Farid Badria | Health Professions | Best Researcher Award

Published on by Shen Awards

Prof. Dr. Farid Badria | Health Professions | Best Researcher Award

Mansoura University, Egypt

Dr. Farid A. Badria is a distinguished Professor of Pharmacognosy at the Faculty of Pharmacy, Mansoura University, Egypt, where he also leads the Liver Research Lab (FAB-Lab). With a career spanning over three decades, he has emerged as a leading expert in natural products research, biomedical sciences, and translational medicine. His research portfolio encompasses phytochemistry, biotechnology, drug discovery, liver diseases, and diagnostic biomarker development. A globally recognized scholar, Dr. Badria’s academic contributions have earned him several prestigious awards, including recognition by Stanford University among the top 2% most-cited scientists in his field. He has held visiting positions at top institutions such as the University of Minnesota and University of Mainz, Germany. His work bridges academia and practical applications by emphasizing sustainable drug development from natural sources, making his research relevant both scientifically and industrially. In addition to his prolific publication record and extensive teaching responsibilities, Dr. Badria has played significant roles in academic governance and research ethics in Egypt. He is a member of multiple scientific organizations and has mentored numerous students and researchers. His commitment to scientific excellence, public health, and academic leadership makes him a worthy contender for the Best Researcher Award.

Professional Profile

Education

Dr. Badria’s educational background reflects his deep expertise in pharmacognosy, cell biology, and natural product chemistry. He holds a Ph.D. in Microbial Transformations and Natural Products Chemistry from the University of Mississippi, USA, where he conducted groundbreaking research on microbial metabolism and structural elucidation of bioactive compounds. Prior to this, he earned a Master of Science in Pharmaceutical Cell Biology and Natural Toxins from the University of Minnesota, USA. His early graduate education also includes an M.Sc. in Pharmacognosy and Natural Products Chemistry from Mansoura University, Egypt, where he began his career as a dedicated researcher. Dr. Badria earned his undergraduate degree, a B.Sc. in Pharmaceutical Sciences, from the same institution. His rigorous academic training in both Egypt and the United States provided him with a comprehensive foundation in natural sciences, advanced analytical techniques, pharmacology, and biotechnology. This diverse and multidisciplinary academic formation has empowered him to investigate complex biomedical problems, develop novel therapeutic strategies, and mentor future generations of scientists in both theoretical and applied pharmaceutical sciences. His global educational experience has also facilitated international collaboration and innovation throughout his career.

Professional Experience

Dr. Farid A. Badria has amassed extensive academic and professional experience, serving in various esteemed roles that have shaped pharmaceutical education and research in Egypt and abroad. At Mansoura University, he has held positions ranging from Assistant Professor (1990) to Full Professor (since 2000), and has served as Head of the Pharmacognosy Department, Head of Applied Drug Research, and Director of the Central Research Lab. As the founding head of the Liver Research Lab (FAB-Lab), he has led pioneering work on liver disorders, natural enzyme modulators, and phytotherapy. His international career includes Visiting Professorships in Medicinal Chemistry at the University of Minnesota (USA) and at Universität Mainz (Germany), where he contributed to research on marine-derived drugs, apoptosis, and biomarkers. He has also served as a consultant and research associate in the United States. Additionally, Dr. Badria has actively contributed to academic governance, including roles on the Supreme Pharmacy Council of Egypt, Clinical Pharmacy Program Committee, and Promotion Committee for Pharmacy Professors. His professional journey reflects a harmonious blend of research innovation, academic leadership, and societal impact. His contributions have not only enriched his institutions but also advanced pharmaceutical sciences at the global level.

Research Interest

Dr. Badria’s research interests are interdisciplinary and pioneering, integrating natural product chemistry, biotechnology, pharmacognosy, and modern therapeutic strategies. His major focus lies in identifying novel bioactive compounds from plants, marine organisms, and microbial sources for use in drug discovery and disease treatment. A core area of his research targets liver diseases, particularly fibrosis and hepatocellular carcinoma, using hepatoselective agents and early diagnostic biomarkers. He is also deeply involved in phytotherapy for skin and metabolic disorders, such as alopecia, hyperpigmentation, obesity, and diabetes, through the modulation of key enzymes like aldose reductase and glucosidase. Additionally, Dr. Badria has worked extensively on cancer diagnostics (particularly ovarian and liver cancer), retinal pathology, and viral infections using both biochemical and AI-based models. His work explores enzyme inhibition as a central therapeutic mechanism and includes studies on topoisomerase, tyrosinase, and hyaluronidase inhibitors. His holistic approach also extends to environmental research, where he has developed biomarkers to monitor marine and freshwater pollution. Overall, Dr. Badria’s research combines traditional natural medicine with cutting-edge biomedical technologies, positioning him at the forefront of translational pharmacognosy and integrative therapeutic sciences.

Research Skills

Dr. Badria possesses a comprehensive and advanced skill set in both laboratory and clinical research methodologies. His expertise in natural products chemistry is demonstrated through his extensive use of chromatographic and spectroscopic techniques (HPLC, NMR, MS, IR, UV) to isolate and characterize novel therapeutic compounds. He is highly skilled in microbial transformation, tissue culture, and biological screening assays for evaluating cytotoxicity, antiviral activity, and enzyme inhibition. His work with mammalian cell culture, tumor induction, cryogenic preservation, and plant tissue cloning reflects his deep command over pharmaceutical biotechnology. Dr. Badria also utilizes AI and computational tools in healthcare research for predictive modeling in liver cancer, obesity, and treatment decision-making. His knowledge of biomarker discovery is applied in both clinical diagnostics and environmental science, identifying indicators for diseases and pollutants in human and aquatic systems. He is adept at experimental design, pharmacological evaluation, and interdisciplinary collaboration. These skills enable him to translate theoretical insights into practical applications, particularly in liver disease therapy, cancer detection, and anti-inflammatory drug development. Dr. Badria’s methodological rigor and technical proficiency are key strengths that drive the success and innovation of his research programs.

Awards and Honors

Dr. Badria’s exceptional research achievements have been recognized with numerous prestigious awards and honors, both nationally and internationally. Most notably, he was cited by Stanford University among the top 2% most-cited scientists in Medicinal and Biomolecular Chemistry. He received the World Intellectual Property Organization (WIPO) Gold Medal in 2011 as the “Best Inventor in Egypt,” and the Third World Academy of Sciences (TWAS) Prize in 2013 for public science communication. His national accolades include multiple State Recognition Awards in Medicine from the Egyptian Academy of Science and Merit of First Class from the President of Egypt in 1998. Internationally, he was honored with the Khawarizmi International Award (Iran, 2000), the NAM S&T Fellowship, and fellowships from UNESCO and the Arab Development Fund. Dr. Badria is also a member of several elite scientific bodies including the American Association for the Advancement of Science (AAAS), New York Academy of Sciences, and the American Society of Pharmacognosy (ASP). These accolades highlight not only his research excellence but also his contributions to science policy, innovation, and knowledge dissemination across borders.

Conclusion

In conclusion, Dr. Farid A. Badria exemplifies the qualities of an outstanding researcher whose work transcends disciplinary boundaries and geographic limitations. His career is characterized by an unwavering commitment to scientific advancement, innovation in natural products research, and impactful contributions to public health, particularly in liver disease treatment and diagnostics. Through his leadership in research, education, and institutional development, he has significantly elevated the scientific standing of Mansoura University and Egypt at large. His global engagements, collaborative initiatives, and mentoring have further amplified the reach and relevance of his work. Dr. Badria’s legacy is built not only on his prolific academic output and technical expertise but also on his dedication to integrating traditional medicine with modern science for the betterment of human health. Given his comprehensive and influential body of work, he is undoubtedly a highly suitable candidate for the Best Researcher Award, representing the highest standards of research integrity, innovation, and social responsibility in the scientific community.

Publications Top Notes

  • Synthesis and biological evaluation of certain α, β-unsaturated ketones and their corresponding fused pyridines as antiviral and cytotoxic agents
    Authors: HI El-Subbagh, SM Abu-Zaid, MA Mahran, FA Badria, AM Al-Obaid
    Journal: Journal of Medicinal Chemistry 43(15), pp. 2915–2921, 2000
    Citations: 536

  • Synthesis and antitumor evaluation of some new 1,3,4-oxadiazole-based heterocycles
    Authors: S Bondock, S Adel, HA Etman, FA Badria
    Journal: European Journal of Medicinal Chemistry 48, pp. 192–199, 2012
    Citations: 266

  • Melatonin, serotonin, and tryptamine in some Egyptian food and medicinal plants
    Author: FA Badria
    Journal: Journal of Medicinal Food 5(3), pp. 153–157, 2002
    Citations: 266

  • Antioxidant and immunomodulatory constituents of henna leaves
    Authors: BR Mikhaeil, FA Badria, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 59(7–8), pp. 468–476, 2004
    Citations: 265

  • Design and synthesis of azolopyrimidoquinolines, pyrimidoquinazolines as antioxidant, anti-inflammatory and analgesic activities
    Authors: ABA El-Gazzar, MM Youssef, AMS Youssef, AA Abu-Hashem, FA Badria
    Journal: European Journal of Medicinal Chemistry 44(2), pp. 609–624, 2009
    Citations: 236

  • Synthesis, antimicrobial, antioxidant, anti-hemolytic and cytotoxic evaluation of new imidazole-based heterocycles
    Authors: BF Abdel-Wahab, GEA Awad, FA Badria
    Journal: European Journal of Medicinal Chemistry 46(5), pp. 1505–1511, 2011
    Citations: 212

  • Synthesis of some new pyrimido[2′,1′:2,3]thiazolo[4,5-b]quinoxaline derivatives as anti-inflammatory and analgesic agents
    Authors: AA Abu-Hashem, MA Gouda, FA Badria
    Journal: European Journal of Medicinal Chemistry 45(5), pp. 1976–1981, 2010
    Citations: 212

  • Natural products for dental caries prevention
    Authors: FA Badria, OA Zidan
    Journal: Journal of Medicinal Food 7(3), pp. 381–384, 2004
    Citations: 189

  • Chemistry and immunomodulatory activity of frankincense oil
    Authors: BR Mikhaeil, GT Maatooq, FA Badria, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(3–4), pp. 230–238, 2003
    Citations: 179

  • Immunomodulatory triterpenoids from the oleogum resin of Boswellia carterii Birdwood
    Authors: FA Badria, BR Mikhaeil, GT Maatooq, MMA Amer
    Journal: Zeitschrift für Naturforschung C 58(7–8), pp. 505–516, 2003
    Citations: 165

Lakovos Nomikos | Health Professions | Outstanding Scientist Award

Published on by Shen Awards

Prof. Dr. Lakovos Nomikos | Health Professions | Outstanding Scientist Award

MD, PhD, FACS from European University Cyprus Nicosia Cyprus, Rea Maternity Hospital Athens Greece, Greece

Dr. Iakovos N. Nomikos, MD, PhD, FACS, is a distinguished academic surgeon with over four decades of experience in clinical practice, research, and medical education. Born on October 1, 1951, in Greece, Dr. Nomikos has dedicated his career to advancing surgical science, with particular contributions in the fields of transplantation biology, metabolic support for critical illness, and oncologic surgery. He has held significant roles in both academic and hospital settings, including Assistant Professor and Chairman of Surgery at major institutions. His extensive training includes fellowships in the United States and the United Kingdom, reflecting a broad international perspective and collaboration. Dr. Nomikos is a Fellow of the American College of Surgeons and a respected member of multiple medical societies. His work spans a wide range of clinical and research domains, and he is widely recognized for his mentorship, leadership, and commitment to the integration of scientific innovation into surgical practice. His contributions have been presented in international conferences, lectures, and numerous publications in both Greek and English literature. Dr. Nomikos continues to serve as an adjunct professor, influencing the next generation of medical professionals while remaining actively engaged in clinical and academic research.

Professional Profile

Education

Dr. Iakovos N. Nomikos pursued his early education at the “Gymnasium” High School in Syros, Cyclades, Greece, from 1963 to 1969, graduating with excellence. He then entered the Medical School of Athens University, where he studied from 1969 to 1975. His academic record was exemplary, achieving an “excellency” degree. The medical program at Athens University included an integrated internship in the final year, consisting of clinical rotations in internal medicine, surgery, pediatrics, and obstetrics-gynecology. This foundational training provided him with a solid grounding in multiple medical disciplines. Following his medical degree, Dr. Nomikos completed a residency in General Surgery at “Evagelismos” Medical Center in Athens from 1975 to 1980. His postgraduate education continued through prestigious fellowships in surgical nutrition, transplantation biology, critical care, and hepatobiliary surgery at world-renowned institutions such as the University of Colorado Health Sciences Center, New York Medical College, and The Queen Elizabeth Hospital in Birmingham, England. These advanced studies and international experiences significantly enriched his clinical knowledge and research capabilities, positioning him as a leader in surgical education and innovation. His diverse academic training has underpinned a career defined by scientific inquiry, clinical excellence, and global collaboration.

Professional Experience

Dr. Nomikos’s professional career spans several decades, marked by progressive responsibility and distinction in surgical practice and academic leadership. His early career began with positions as an attending surgeon at Evangelismos Medical Center and Larissa General Hospital in Greece. From 1987 to 2004, he served in the Department of Surgery at Tzanion General Hospital, Piraeus, progressing from attending surgeon to associate director. In 2004, he was appointed Chairman of Surgery at Metaxa Cancer Memorial Hospital, where he served until 2018, overseeing clinical operations, research, and resident education. Since 2019, he has continued practicing surgery in the private sector at Rea Maternity Hospital and Metropolitan General Hospital in Athens. In parallel with his clinical duties, Dr. Nomikos has held academic positions, including Lecturer and Assistant Professor of Surgery at Athens University and currently serves as Adjunct Professor of Surgery at the European University of Cyprus. His teaching responsibilities span both the School of Medicine and the Department of Life Sciences. Throughout his career, he has played a vital role in shaping surgical education programs and mentoring young professionals. His leadership has consistently integrated evidence-based practice with clinical innovation, reinforcing his reputation as a pillar of surgical excellence in Greece and beyond.

Research Interests

Dr. Iakovos N. Nomikos has cultivated a robust and diverse research portfolio throughout his career, combining basic science with applied clinical studies. His early research focused on transplantation biology, with particular emphasis on pancreatic islet transplantation for insulin-dependent diabetes mellitus (IDDM), examining graft destruction mechanisms. He has also extensively studied ischemia-reperfusion injury, a critical area in transplantation and trauma surgery. Another major area of interest includes the cellular biology of peritonitis, where he has investigated immune response and inflammation in abdominal infections. In applied research, Dr. Nomikos has addressed practical clinical challenges such as peritoneal infections, neo-adjuvant chemotherapy for solid tumors, metabolic responses in critically ill surgical patients, and functional staging of acute surgical illness. His interest in surgical metabolism and nutrition has informed clinical protocols that improve recovery and outcomes in post-operative and intensive care settings. These research interests not only highlight his interdisciplinary approach but also reflect a commitment to enhancing surgical care through scientific advancement. Dr. Nomikos’s work stands at the intersection of innovation and clinical relevance, aiming to translate laboratory discoveries into improved patient outcomes. His efforts have contributed significantly to the fields of surgical oncology, critical care, and transplant medicine.

Research Skills

Dr. Nomikos brings an exceptional set of research skills developed through decades of clinical practice, international training, and academic scholarship. His expertise spans both bench-side experimentation and bedside clinical research. In basic science, he is skilled in experimental models of islet transplantation, immunological assays, and the study of cellular mechanisms involved in ischemia-reperfusion injury and peritonitis. His training in the United States and the UK equipped him with advanced competencies in surgical research methodologies, including critical care and transplant-related studies. In clinical research, he excels in protocol development, data analysis, clinical trial execution, and outcome evaluation, particularly in surgical oncology and critical care settings. He has led and participated in projects focusing on chemotherapy protocols, surgical metabolic support, and the functional assessment of acute surgical conditions. Dr. Nomikos is also adept at medical writing, scientific presentation, and research mentoring, contributing significantly to academic publications, oral communications, and educational leadership. His ability to bridge theoretical science with surgical practice exemplifies translational research at its best. These multifaceted skills have enabled him to drive innovations in patient care, guide clinical decision-making, and mentor a generation of surgeon-scientists within Greece and internationally.

Awards and Honors

Dr. Iakovos N. Nomikos has received numerous honors and awards in recognition of his exceptional contributions to surgery, research, and education. He is a Fellow of the American College of Surgeons (FACS), a prestigious international credential that signifies excellence in surgical practice and ethics. His career achievements have been acknowledged through several institutional, national, and international recognitions, including leadership positions in major hospitals and academic programs. He has been honored for his work in surgical oncology, critical care, and transplantation science. Dr. Nomikos’s scholarly efforts have been consistently featured in leading international congresses, where he has delivered invited lectures, chaired roundtable discussions, and presented scientific exhibits. His teaching accomplishments have also been recognized by academic institutions where he has played a pivotal role in curriculum development and resident training. Moreover, his influence extends through professional societies, where he holds memberships that reflect both his scientific stature and dedication to interdisciplinary collaboration. These accolades collectively underscore a career marked by lifelong service to advancing surgical science and mentoring future generations of clinicians. His awards affirm his lasting impact on both the academic and medical communities, validating his status as a respected leader in the global surgical field.

Conclusion

Dr. Iakovos N. Nomikos exemplifies the ideal candidate for recognition through a Research for Outstanding Scientist Award. His career is defined by a seamless integration of academic rigor, clinical excellence, and translational research. From pioneering studies in transplantation biology to practical innovations in critical care and oncologic surgery, he has consistently addressed key challenges in surgical practice through scientific inquiry. His mentorship, leadership, and continued contributions as an adjunct professor demonstrate ongoing relevance and impact. With a history of productive research collaborations, international training, and a strong publication and presentation record, Dr. Nomikos has significantly advanced both theoretical and applied surgical knowledge. Although further visibility through recent high-impact publications or patent disclosures could strengthen his profile, the depth, breadth, and longevity of his contributions are clear. He has made lasting advancements in patient care, surgical methodology, and medical education. In conclusion, Dr. Nomikos’s distinguished achievements over several decades merit recognition not only as a leading figure in his field but also as a scientist whose work has tangibly improved lives and enriched the broader medical community. His career is a model of what sustained excellence and dedication in clinical research can accomplish.

Publications Top Notes

  • Combined treatment with nicotinamide and desferrioxamine prevents islet allograft destruction in NOD mice
    Authors: IN Nomikos, SJ Prowse, P Carotenuto, KJ Lafferty
    Journal: Diabetes, 35(11), 1302–1304
    Citations: 159
    Year: 1986

  • Prevention of postischaemic lipid peroxidation and liver cell injury by iron chelation
    Authors: R Omar, I Nomikos, G Piccorelli, J Savino, N Agarwal
    Journal: Gut, 30(4), 510–514
    Citations: 139
    Year: 1989

  • Involvement of O2 radicals in ‘autoimmune’ diabetes
    Authors: IN Nomikos, Y Wang, KJ Lafferty
    Journal: Immunology and Cell Biology, 67(1), 85–87
    Citations: 97
    Year: 1989

  • Washing with or without chloramphenicol in the treatment of peritonitis: a prospective, clinical trial
    Authors: IN Nomikos, K Katsouyanni, AN Papaioannou
    Journal: Surgery, 99(1), 20–25
    Citations: 64
    Year: 1986

  • Effect of cyclosporine on immunologically mediated diabetes in nonobese diabetic mice
    Authors: Y Wang, M McDuffie, IN Nomikos, L Hao, KJ Lafferty
    Journal: Transplantation, 46(2), 101S–106S
    Citations: 49
    Year: 1988

  • Current surgical aspects of palliative treatment for unresectable pancreatic cancer
    Authors: K Karapanos, IN Nomikos
    Journal: Cancers, 3(1), 636–651
    Citations: 28
    Year: 2011

  • Protective and damaging aspects of healing: A review
    Authors: IN Nomikos, C Malizos, NC Vamvakopoulos
    Journal: Wounds: A Compendium of Clinical Research and Practice, 18(7), 177–185
    Citations: 28
    Year: 2006

  • Practical approaches to effective management of intestinal radiation injury: benefit of resectional surgery
    Authors: N Perrakis, E Athanassiou, D Vamvakopoulou, M Kyriazi, H Kappos, …
    Journal: World Journal of Gastroenterology, 17(35), 4013
    Citations: 27
    Year: 2011

  • Carcinoma of the inguinal region arising from endometriosis of the round ligament. Report of a case
    Authors: J Elemenoglou, A Skopelitou, I Nomikos
    Journal: European Journal of Gynaecological Oncology, 14(1), 28–32
    Citations: 27
    Year: 1993

  • Tamoxifen-induced endometrial polyp. A case report and review of the literature
    Authors: IN Nomikos, J Elemenoglou, J Papatheophanis
    Journal: European Journal of Gynaecological Oncology, 392, 2936
    Citations: 23
    Year: 1998

Risa Yamada | Health Professions | Best Researcher Award

Published on by Shen Awards

Ms. Risa Yamada | Health Professions | Best Researcher Award

Researcher from National Center of Neurology and Psychiatry, Japan

Risa Yamada is an esteemed Chief Researcher at the Department of Preventive Intervention for Psychiatric Disorders, National Institute of Mental Health, National Center of Neurology and Psychiatry, Japan. Her research primarily focuses on neuropsychopharmacology, epidemiology, and neurophysiology in patients with psychiatric disorders such as schizophrenia, mood disorders, and substance abuse. She is renowned for her pioneering work in the epidemiology of gambling disorders, exploring the impact of comorbid behavioral addiction. Her research has yielded significant insights into the effectiveness of serotonin-5-HT1A receptor partial agonists for cognitive enhancement in schizophrenia, with findings published in prestigious journals. Additionally, she is conducting cutting-edge research on transcranial photobiomodulation to ameliorate cognitive deficits in schizophrenia. Yamada has made notable contributions to the understanding of depression severity and the role of adverse childhood experiences in mood disorders. With a background in clinical psychology and neuropsychopharmacology, she is a rising leader in the field of psychiatric research.

Professional Profile

Education

Risa Yamada completed her medical education at the Jikei University School of Medicine, earning her Ph.D. in February 2023. Prior to this, she received a Bachelor of Science degree from Toho University in 2011 and a Master of Psychology from Teikyo University in 2018. Throughout her educational journey, she focused on the intersection of clinical psychology and psychiatry, particularly in understanding the neuropsychological aspects of psychiatric disorders. Her academic development laid a strong foundation for her subsequent research career. In addition to her medical degrees, Yamada holds certifications as a Clinical Psychologist (2019) and a Public Psychologist (2019), which further demonstrate her expertise and commitment to advancing psychological and psychiatric research. These educational qualifications, coupled with her practical research experience, allow Yamada to contribute significantly to the development of new treatment strategies for psychiatric conditions, particularly those related to cognitive dysfunction and behavioral addictions.

Professional Experience

Risa Yamada currently serves as the Chief Researcher at the Department of Preventive Intervention for Psychiatric Disorders at the National Institute of Mental Health, part of the National Center of Neurology and Psychiatry in Tokyo, Japan. She has been in this role since September 2021 and has been instrumental in leading research focused on cognitive impairments in psychiatric conditions such as schizophrenia. Yamada’s career began as a Research Associate in the Department of Mental Disorder Research at the National Center of Neurology and Psychiatry from 2018 to 2021, where she investigated depression severity and its links to adverse childhood experiences and coping styles. Prior to her current position, she conducted a doctoral research project at Jikei University, where she explored the relationship between gambling disorder and psychiatric conditions. Her extensive experience spans multiple research settings, with her work having a significant impact on clinical understanding and treatment development for various psychiatric conditions. Yamada’s role as a researcher and educator also extends to her involvement in several leading academic societies in psychiatry and neuropsychopharmacology.

Research Interests

Risa Yamada’s research interests lie at the intersection of clinical psychology, psychiatry, and neuropsychopharmacology. She is deeply engaged in studying the cognitive and neurophysiological aspects of psychiatric disorders, particularly schizophrenia, mood disorders, and behavioral addictions such as gambling disorders. Her work focuses on the use of neuropsychological methods to explore the biological and psychological underpinnings of these conditions, with a particular emphasis on cognitive impairment. One of her notable research projects involves studying the augmentation of cognitive function in schizophrenia using serotonin-5-HT1A receptor partial agonists, a promising avenue for improving psychotic symptoms and cognitive deficits. Additionally, Yamada is investigating the potential of transcranial photobiomodulation, a non-invasive brain stimulation technique, to address cognitive impairments in patients with schizophrenia. She also explores the relationship between adverse childhood experiences and mood disorders, with the goal of identifying effective biomarkers and treatments for negative valence in psychiatric conditions. Her research aims to advance both theoretical understanding and practical interventions for these prevalent and challenging mental health conditions.

Research Skills

Risa Yamada possesses a diverse and advanced skill set in clinical research, particularly in the fields of neuropsychopharmacology, epidemiology, and neurophysiology. She is proficient in conducting meta-analyses and cross-sectional studies, particularly related to psychiatric disorders and cognitive dysfunction. Her expertise in neuropsychological methods allows her to investigate complex interactions between psychological traits and psychiatric conditions. Yamada is skilled in using clinical scales and neurophysiological tools, such as skin conductivity measures, to assess psychological traits like interoception and alexithymia in relation to psychiatric conditions. Furthermore, she has experience in neuroimaging techniques, including the use of transcranial photobiomodulation for brain stimulation. Yamada’s work with behavioral addiction, particularly gambling disorders, demonstrates her ability to apply epidemiological methods to mental health research. She is also adept at analyzing large-scale clinical data sets and using statistical models to explore the relationship between psychiatric symptoms and demographic variables. These research skills enable her to lead impactful studies that contribute both to the scientific community and to practical applications in the treatment of psychiatric disorders.

Awards and Honors

Risa Yamada has received recognition for her contributions to psychiatric research, particularly in the areas of neuropsychopharmacology and behavioral addiction. She has been awarded several academic honors, including recognition for her groundbreaking research on gambling disorders, which was the first of its kind in Japan. Her work on cognitive enhancement therapies for schizophrenia has been published in high-impact journals, earning her a reputation as a leader in the field. While she has not yet received large-scale awards, her growing recognition within the academic community and her role as Chief Researcher at the National Institute of Mental Health reflect her increasing influence. Yamada’s contributions to psychiatric research have been acknowledged through invitations to present her findings at prestigious international conferences. She is also a member of several leading professional societies, including the Collegium Internationale Neuro-Psychopharmacologicum and the Japanese Society of Neuropsychopharmacology, further solidifying her status as a respected researcher.

Conclusion

Risa Yamada is a highly promising and accomplished researcher in the field of psychiatry, with a focus on neuropsychopharmacology, neurophysiology, and epidemiology. Her work has already made a significant impact, particularly in the understanding of cognitive dysfunction in schizophrenia and gambling disorders. With a robust educational background and extensive professional experience, Yamada is well-positioned to continue contributing to the advancement of psychiatric research. Her innovative approach to non-invasive brain stimulation, alongside her focus on biomarkers for psychiatric conditions, highlights her potential for further breakthroughs. While her research is primarily centered on schizophrenia and mood disorders, expanding her focus to other psychiatric conditions would enhance the breadth of her contributions. With continued growth in international collaboration and further emphasis on translational research, Yamada has the potential to make a lasting impact on both clinical practice and scientific understanding in the field of psychiatry.

Publications Top Notes

  • Clinical Significance of Psychiatric Comorbidities Among Outpatients With Gambling Disorder in Japan: A 12-Month Follow-Up Study
    Authors: Yamada, R., Stickley, A., Shigeta, M., Miyata, H.
    Year: 2025

  • Semantic memory disorganization linked to social functioning in patients with schizophrenia
    Authors: Wada, A., Sumiyoshi, C., Yoshimura, N., Hashimoto, R., Matsumoto, J., Stickley, A., Yamada, Y., Kikuchi, A., Kubota, R., Matsui, M., Nakachi, K., Fujimaki, C., Adachi, L., Yamada, R., Sumiyoshi, T.
    Year: 2025

  • Autistic trait severity in early schizophrenia: Role in subjective quality of life and social functioning
    Authors: Wada, A., Yamada, R., Yamada, Y., Sumiyoshi, C., Hashimoto, R., Matsumoto, J., Kikuchi, A., Kubota, R., Matsui, M., Nakachi, K., Fujimaki, C., Adachi, L., Stickley, A., Yoshimura, N., Sumiyoshi, T.
    Year: 2025

  • Problematic gambling and psychotic-like experiences: Findings from Japan
    Authors: Stickley, A., Shirama, A., Yamada, R., Sumiyoshi, T.
    Year: 2024

  • Augmentation therapy with serotonin1A receptor partial agonists on neurocognitive function in schizophrenia: A systematic review and meta-analysis
    Authors: Yamada, R., Wada, A., Stickley, A., Yokoi, Y., Sumiyoshi, T.
    Year: 2023

  • Effect of 5-HT1A Receptor Partial Agonists of the Azapirone Class as an Add-On Therapy on Psychopathology and Cognition in Schizophrenia: A Systematic Review and Meta-Analysis
    Authors: Yamada, R., Wada, A., Stickley, A., Yokoi, Y., Sumiyoshi, T.
    Year: 2023

  • Prevalence and Clinical Significance of Psychiatric Comorbidities With Gambling Disorder in 12 Clinical Settings in Japan
    Authors: Yamada, R., Miyashita, K., Hashimoto, T. M., et al.
    Year: 2023

  • Discrepancy between Clinician-rated and Self-reported Depression Severity is Associated with Adverse Childhood Experience, Autistic-like Traits, and Coping Styles in Mood Disorders
    Authors: Yamada, R., Fujii, T., Hattori, K., et al.
    Year: 2023

  • The relationship between severity of drug problems and perceived interdependence of drug use and sexual intercourse among adult males in drug addiction rehabilitation centers in Japan
    Authors: Yamada, R., Shimane, T., Kondo, A., Yonezawa, M., Matsumoto, T.
    Year: 2021